semaglutide nejm weight loss New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) https://nej.md/444aW7f Cagrilintide–Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) https://nej.md/4ehQwLk Semaglutide in Adults with Type

Free T4 (Thyroxine): This is the "storage" version of the hormone

Patient-Reported Mood and Anxiety Improvements on GLP-1 Therapy Observational reports and informal patient surveys consistently document improved mood, reduced anxiety, and better stress tolerance among individuals taking semaglutide or tirzepatide

Rather, they represent two sides of the same coin, interconnected through the intricate, bidirectional communication network known as the gut-brain axis

For physically and mentally active individuals, this is crucial, as it is during delta sleep that memory consolidation and the repair of micro-damage in muscle tissue occur